1 completed. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
Follow Exendin-9,39: new trials by email Literature Review of Exendin-9,39 trials Research Report on Exendin-9,39
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Dose-response of the Effects of Exendin-9,39 on GI Symptoms and Food Intake Exendin-9,39, Saline - Obesity, Diabetes | Phase 1 | Completed | Mayo Clinic | 3 | 2014-05-01 | 2019-10-23 |
Diabetes Mellitus (1) · Obesity (1)
Mayo Clinic (1)
United States (1)
Adrian Vella, MD (1)
R01DK082396 (1), UL1RR024150 (1)